Xanthi I. Couroucli, M.D.
- Assistant Professor of Pediatrics — Neonatology
- Attending Neonatologist at Baylor College of Medicine,
Department of Pediatrics
- American Board of Pediatrics, Pediatrics, 1995–Present
- American Board of Pediatrics, Neonatal–Perinatal Medicine, 1999–Present
Current appointed positions in professional organizations
- Full member of the Medical Association of Athens, Greece, 1987–Present
- Full member of the General Medical Council, London, UK, 1987–Present
- Member, American Academy of Pediatrics, 1995–Present
- Fellow, American Academy of Pediatrics, Elected position, 1995–Present
- Member, Division of Neonatal-Perinatal Medicine, American Academy of Pediatrics, 1999–Present
- Member, American Society for Pharmacology and Experimental Therapeutics,
Elected position, 2000–Present
- Member, Society of Toxicology, Elected position, 2001–Present
- Member, American Thoracic Society, 2001–Present
- Member, Association for Research in Vision and Ophthalmology, 2004–Present
- Neonatal Resuscitation Program Instructor, 2005–Present
- Member, Texas Medical Association, 2009–Present
- Member, Harris County Medical Society, 2009–Present
- Member, American Association for the Advancement of Science, 2010–Present
- M.D., University of Athens, Greece, 09/1980–03/1987
- Residency in Pediatrics: Medical School of Oxford, Manchester, Birmingham, and London University, UK, 08/1987–07/1990
- 3rd year Pediatric Resident: Schneider Children's Hospital,
Long Island Jewish Medical Center, New York, NY, 05/1994–06/1995
- Fellow in Pediatric Cardiology: The Children's National Medical Center,
Washington DC, 07/1995–08/1996
- Fellow in Pediatrics - Neonatology: Baylor College of Medicine, Houston, TX, 09/1996–09/1999
- Molecular Toxicology
- Bronchopulmonary Dysplasia
- Retinopathy of Prematurity
- Asthma and Diabetic Retinopathy
- Couroucli XI, Liang YH, Jiang W, Wang L, Barrios R, Yang P, Moorthy B. Prenatal administration of the cytochrome P4501A inducer, B-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants. Toxicol Appl Pharmacol 2011; 256(2):83-94.
- Shivanna B, Chu C, Welty SE, Jiang W, Wang L, Couroucli XI, Moorthy B. Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor. Free Radic Biol Med 2011; (10):1910-7.
- Shivanna B, Jiang W, Wang L, Couroucli XI, Moorthy B. Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes. J Pharmacol Exp Ther 2011; 339(1):106-14.
- Jiang W, Couroucli XI, Wang L, Barrios R, Moorthy B. Augmented oxygen-mediated transcriptional activation of cytochrome P450 (CYP)1A expression and increased susceptibilities to hyperoxic lung injury in transgenic mice carrying the human CYP1A1 or mouse 1A2 promoter in vivo. Biochem Biophys Res Commun. 2011; 407(1):79-85.